AOP Health US LLC: RAPIBLYK(R) (landiolol) Approved by FDA for Use in Pediatric Patients with Supraventricular Tachycardia

RAPIBLYK (R) is an ultra-short-acting, selective beta-1 adrenergic receptor blocker administered intravenously in a monitored hospital setting. Its pharmacological profile allows for rapid onset and ...
MPR

Rapiblyk Receives FDA Approval for Pediatric SVT Treatment

Approval was supported by the phase 3 LANDI-PED study, which demonstrated significant heart rate reduction and conversion to normal sinus rhythm in pediatric patients.
clinicaladvisor.com

A faster heart rate and numbness: Is the patient having a heart attack?

Untreated or unmanaged, SVT can lead to other possibly fatal heart abnormalities. Patients are advised to practice a cardiac-friendly diet and lifestyle (low sodium, little to no caffeine or alcohol, ...

Why SVT Often Goes Undiagnosed And What You Can Do About It?

Supraventricular tachycardia (SVT) often goes undiagnosed due to subtle or intermittent symptoms. Learn why it’s missed and ...
Medscape

Long-Term Outcomes of Ivabradine in Inappropriate Sinus Tachycardia Patients

Background Inappropriate sinus tachycardia (IST) is characterized by persistent and disproportional elevation of heart rate (HR). Ivabradine has been successfully used in some patients. Methods Twenty ...
Healio

Ventricular tachycardia ablation plus subcutaneous ICD implant appears beneficial

Please provide your email address to receive an email when new articles are posted on . Patients with scar-related ventricular tachycardia (VT) who received VT ablation plus a subcutaneous ICD had ...
Medscape

Long-Term Outcomes of Ivabradine in Inappropriate Sinus Tachycardia Patients

Juan Benezet-Mazuecos, M.D.; José M. Rubio, M.D.; PH.D., Jerónimo Farré , M.D., PH.D.; Miguel Á. Quinñones, M.D.; Pepa Sanchez-Borque, M.D.; Ester Macía, M.D ...